返回 Agendas
Covance Innovation Theater: Advances in Risk-Based Monitoring: Transforming Drug Development Through Efficient Workflows, Big Data and Elegant Software
Session Chair(s)
Fortrea
United States
Covance’s risk-based monitoring (RBM) platform provides our clients with the best-in-class implementation of the RBM principles put forth by FDA, EMA and TransCelerate, and enhanced by Covance’s operational and clinical expertise. The platform facilitates all aspects of RBM through timely, secure and integrated access to all relevant trial data, supported by a robust clinical data integration layer and a set of modern web-based interfaces.
注册方法
Registration override should work.